[Skip to Navigation]
Views 11,593
Citations 0
JAMA Dermatology Clinical Evidence Synopsis
August 19, 2020

Vaccination Against Human Papillomavirus

Author Affiliations
  • 1The George Washington University School of Medicine and Health Sciences, Washington, DC
  • 2Department of Dermatology, Kaiser Permanente, San Francisco, California
JAMA Dermatol. 2020;156(11):1246-1247. doi:10.1001/jamadermatol.2020.2927
Abstract

Clinical Question  Who should receive human papillomavirus (HPV) vaccination?

Bottom Line  Catch-up vaccination is now recommended for all persons through age 26 years. For persons aged 27 through 45 years, clinicians and patients should now jointly decide whether HPV vaccination is appropriate. Routine HPV vaccination at age 11 or 12 years (or as early as age 9 years) continues to be recommended.

Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words
    ×